-85%

est. 2Y upside i

HealthcareSeries A

Rank

#4178

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

MediSage presents a risky equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (10%)+300%

Strategic partnerships and successful expansion of new tools like WOW Clinics drive significant user engagement and revenue growth, reaching $15M ARR. An acquisition at $119M by a larger healthcare or pharma company results in a 300% return for common shareholders.

Base (30%)+12%

MediSage maintains its niche, growing modestly through existing partnerships and new features like WOW Clinics. An acquisition at $38.5M allows for a modest 12% return for common shareholders after accounting for investor preferences.

Bear (60%)-89%

Intense competition from Doximity and Sermo, coupled with internal operational challenges evidenced by the significant employee reduction, leads to stalled growth and a down-round acquisition at $10M. After liquidation preferences, common stock holders realize an 89% loss.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Funding Intensity

20%

Investors hold $7M in liquidation preferences, meaning common shareholders would only receive proceeds after this amount is paid out.

Dilution Risk

high

Given the current growth rate and Series A stage, additional funding rounds are highly probable, leading to further dilution of common stock.

Secondary Liquidity

none

As a relatively early-stage, privately held company, there is no active secondary market for MediSage's equity.

Questions to Ask at the Interview

Strategic questions based on MediSage's data — designed to show you've done your homework.

  • 1

    “The employee count decreased by 43% from July 2024 to July 2025. Could you elaborate on the reasons behind this significant workforce reduction and how it has impacted the company's strategic priorities and operational capacity?”

  • 2

    “MediSage's revenue growth is currently 13% YoY. Given the large TAM and SAM, what are the key strategies and product initiatives planned to accelerate growth significantly beyond this rate in the next 12-24 months, especially considering the competitive landscape with Doximity?”

  • 3

    “With $7M in total funding and a $35M valuation, there's a meaningful liquidation preference for investors. How does MediSage envision its path to a liquidity event (e.g., acquisition or IPO) for common shareholders within a 3-5 year timeframe, and what milestones are critical to achieving a favorable outcome for employees?”

Community

Valuation Sentiment

Our model estimates -85% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.